Tag: Pharmaceutical GMP violations

How PMDA’s GMP Guidelines Affect Pharmaceutical Manufacturing in Japan

January 20, 2025 digi

How PMDA’s GMP Guidelines Affect Pharmaceutical Manufacturing in Japan Understanding PMDA’s GMP Guidelines and Their Impact on Pharmaceutical Manufacturing in Japan Introduction to PMDA and GMP in Japan The Pharmaceuticals and Medical Devices Agency (PMDA) is Japan’s primary regulatory authority for ensuring the quality, safety, and efficacy of pharmaceutical products. Its stringent Good Manufacturing Practices…

GMP in Asia (PMDA, NMPA, KFDA)

GMP in Europe (EMA, MHRA)

January 20, 2025 digi

GMP in Europe (EMA, MHRA) Understanding GMP Compliance in Europe: EMA and MHRA Guidelines Introduction to GMP in Europe In the European pharmaceutical industry, maintaining Good Manufacturing Practices (GMP) is a cornerstone of ensuring the safety, quality, and efficacy of medicinal products. Regulatory compliance in Europe is governed by the European Medicines Agency (EMA) and…

Read More “GMP in Europe (EMA, MHRA)” »

GMP in Europe (EMA, MHRA)

Understanding GMP Compliance in Emerging Markets: GCC, Latin America, and Africa

January 20, 2025 digi

Understanding GMP Compliance in Emerging Markets: GCC, Latin America, and Africa A Step-by-Step Guide to Understanding GMP Compliance in Emerging Markets Introduction to GMP in Emerging Markets Good Manufacturing Practices (GMP) form the backbone of pharmaceutical quality standards, ensuring the safety, efficacy, and consistency of medicinal products. In emerging markets such as the Gulf Cooperation…

GMP in Emerging Markets (GCC, Latin America, Africa)

GMP in North America (FDA, Health Canada)

January 20, 2025 digi

GMP in North America (FDA, Health Canada) Comprehensive Guide to GMP Standards in North America Introduction to GMP in North America Good Manufacturing Practices (GMP) are a cornerstone of pharmaceutical manufacturing, ensuring that all products are produced consistently and controlled according to quality standards. In North America, two primary agencies oversee GMP compliance: the Food…

GMP in North America (FDA, Health Canada)

How Schedule M Revised Aligns with Global GMP Standards

January 20, 2025 digi

How Schedule M Revised Aligns with Global GMP Standards Understanding the Alignment of Schedule M Revised with Global GMP Standards Introduction to Schedule M Revised and Global GMP Standards The revision of Schedule M under the Drugs and Cosmetics Rules, 1945, marks a significant milestone for the Indian pharmaceutical industry. By introducing enhanced Good Manufacturing…

GMP in India

Understanding GMP Regulations in Asia: A Guide to PMDA, NMPA, and KFDA

January 20, 2025 digi

Understanding GMP Regulations in Asia: A Guide to PMDA, NMPA, and KFDA A Detailed Guide to GMP Regulations in Asia: PMDA, NMPA, and KFDA Introduction to GMP in Asia In the pharmaceutical industry, Good Manufacturing Practices (GMP) are essential for ensuring product quality, safety, and efficacy. Asia, home to some of the world’s largest pharmaceutical…

GMP in Asia (PMDA, NMPA, KFDA)

GMP in Emerging Markets (GCC, Latin America, Africa)

January 20, 2025 digi

GMP in Emerging Markets (GCC, Latin America, Africa) Exploring GMP Compliance in Emerging Markets: GCC, Latin America, and Africa Introduction to GMP in Emerging Markets Good Manufacturing Practices (GMP) are fundamental to the pharmaceutical industry, ensuring the safety, efficacy, and quality of medicinal products. While developed markets have well-established GMP frameworks, emerging markets such as…

GMP in Emerging Markets (GCC, Latin America, Africa)

GMP in Asia (PMDA, NMPA, KFDA)

January 20, 2025 digi

GMP in Asia (PMDA, NMPA, KFDA) A Comprehensive Overview of GMP Regulations in Asia: PMDA, NMPA, and KFDA Introduction to GMP in Asia The pharmaceutical industry in Asia is governed by stringent Good Manufacturing Practices (GMP) to ensure the safety, efficacy, and quality of medicinal products. Regulatory authorities such as Japan’s Pharmaceuticals and Medical Devices…

GMP in Asia (PMDA, NMPA, KFDA)

The Role of Schedule M Revised in Enhancing Drug Quality in India

January 19, 2025 digi

The Role of Schedule M Revised in Enhancing Drug Quality in India How Schedule M Revised is Improving Pharmaceutical Product Quality in India Introduction to Schedule M Revised and Drug Quality The quality of pharmaceutical products is paramount for ensuring patient safety and effective treatment outcomes. In India, the revision of Schedule M under the…

GMP in India

Overview of Schedule M Revised: Impact on GMP Compliance in India

January 19, 2025 digi

Overview of Schedule M Revised: Impact on GMP Compliance in India Understanding the Revised Schedule M: Enhancing GMP Compliance in India Introduction to Schedule M Revised Schedule M of the Drugs and Cosmetics Rules, 1945, outlines the requirements for Good Manufacturing Practices (GMP) for pharmaceuticals in India. The recent revisions to Schedule M have introduced…

GMP in India